Johnson & Johnson Innovation and BARDA hosted the 2025 BLUE KNIGHT™ Showcase at BIO 2025 in Boston. This annual global conversation is designed to bring together healthcare innovators and funders to build impactful relationships and foster innovation in addressing global public health threats.
BLUE KNIGHT™ is a unique joint initiative between Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services.
A new startup company that could profoundly change the sterility testing techniques of vaccines and other biopharmaceutical products has been launched with the support of the Texas A&M Engineering Experiment Station (TEES) Office of Commercialization and Entrepreneurship.
Howdy Ags! Today we are thrilled to be joined by CEO of HelioWave Technologies and triple crown Aggie, Adrian Guzman. Adrian brings us through his journey as an entrepreneur, his impactful and far-reaching goals, and how he balances his several different company roles. We want to thank Adrian for speaking to us today, and we can’t wait to see how he changes the world.
Join the pioneers in leveraging our rapid testing solutions for exceptional quality assurance.
